JP expects 2007 Tyzeka/Sebivo worldwide sales to “come close” to the prior guidance of $20M. He says sales are slower than expected in the US, but higher than expected elsewhere.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”